Persistent chylomicronemia is defined by high plasma triglycerides on several occasions that is unresponsive to conventional treatments.
Watch the first episode of IAS’ new Leading Insights series to hear Prof. Raul Santos and Prof. Gerald Watts discuss the PALISADE study’s findings, noting how plozasiran demonstrated it can meet the treatment gap for patients with familial chylomicronemia syndrome whether the rare disease is clinically defined or genetically confirmed. IAS received an unrestricted grant from Arrowhead […]
This paper presents a summary of primary prevention measures for atherosclerotic cardiovascular disease caused by elevated low-density lipoprotein cholesterol, and other cardio-metabolic risk factors such as obesity and diabetes, as well as hypertension
Serie de videos en español con especialistas en ASCVD para discusión sobre el riesgo cardiovascular en América Latina.
Serie de videos en español con especialistas en ASCVD para discusión sobre la quilomicronemia familiar en América Latina.
Peter Libby, MD, and Jessica M. Peña, MD, MPH, FACC, FNLA, discuss the role that inflammation plays in atherosclerosis.
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
